Alpha-thalassemia: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
Alpha-thalassemia | {{SI}} | ||
{{Infobox medical condition | |||
| name = Alpha-thalassemia | |||
| image = [[File:Thalassemia_alpha.jpg|250px]] | |||
| caption = Blood smear showing microcytic hypochromic anemia typical of alpha-thalassemia | |||
| synonyms = α-thalassemia | |||
| pronounce = | |||
| specialty = [[Hematology]] | |||
| symptoms = [[Anemia]], [[fatigue]], [[pallor]], [[jaundice]], [[splenomegaly]] | |||
| complications = [[Hydrops fetalis]], [[iron overload]] | |||
| onset = Birth | |||
| duration = Lifelong | |||
| types = [[Alpha-thalassemia trait]], [[Hemoglobin H disease]], [[Hemoglobin Bart's hydrops fetalis]] | |||
| causes = Genetic mutations in the [[HBA1]] and [[HBA2]] genes | |||
| risks = Family history, [[Southeast Asian]], [[Mediterranean]], [[Middle Eastern]], [[African]] descent | |||
| diagnosis = [[Complete blood count]], [[hemoglobin electrophoresis]], [[genetic testing]] | |||
| differential = [[Beta-thalassemia]], [[iron deficiency anemia]], [[sideroblastic anemia]] | |||
| prevention = Genetic counseling | |||
| treatment = [[Blood transfusion]], [[iron chelation therapy]], [[bone marrow transplant]] | |||
| medication = [[Deferoxamine]], [[Deferasirox]] | |||
| prognosis = Variable, depending on type | |||
| frequency = Common in certain populations | |||
}} | |||
[[File:Illu blood cell lineage.jpg|Blood cell lineage|thumb]] | |||
[[File:DOMR-6-350-g004.gif|Alpha-thalassemia|left|thumb]] | |||
[[File:Red Blood Cell abnormalities.png|Red Blood Cell abnormalities|left|thumb]] | |||
Alpha-thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen to cells throughout the body. Alpha-thalassemia is caused by mutations in the HBA1 and HBA2 genes, which are responsible for the production of alpha-globin, a component of hemoglobin. | Alpha-thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen to cells throughout the body. Alpha-thalassemia is caused by mutations in the HBA1 and HBA2 genes, which are responsible for the production of alpha-globin, a component of hemoglobin. | ||
==Pathophysiology== | ==Pathophysiology== | ||
In alpha-thalassemia, the production of alpha-globin chains is reduced or absent. This leads to an imbalance in the ratio of alpha to beta-globin chains, resulting in the formation of abnormal hemoglobin molecules. The severity of the disease depends on the number of affected alpha-globin genes. | In alpha-thalassemia, the production of alpha-globin chains is reduced or absent. This leads to an imbalance in the ratio of alpha to beta-globin chains, resulting in the formation of abnormal hemoglobin molecules. The severity of the disease depends on the number of affected alpha-globin genes. | ||
===Genetic Basis=== | ===Genetic Basis=== | ||
The HBA1 and HBA2 genes are located on chromosome 16. Each person has four alpha-globin genes, two from each parent. The severity of alpha-thalassemia is determined by the number of gene deletions: | The HBA1 and HBA2 genes are located on chromosome 16. Each person has four alpha-globin genes, two from each parent. The severity of alpha-thalassemia is determined by the number of gene deletions: | ||
* '''Silent Carrier''': One gene deletion, usually asymptomatic. | * '''Silent Carrier''': One gene deletion, usually asymptomatic. | ||
* '''Alpha-thalassemia Trait''': Two gene deletions, mild anemia. | * '''Alpha-thalassemia Trait''': Two gene deletions, mild anemia. | ||
* '''Hemoglobin H Disease''': Three gene deletions, moderate to severe anemia. | * '''Hemoglobin H Disease''': Three gene deletions, moderate to severe anemia. | ||
* '''Hydrops Fetalis''': Four gene deletions, usually fatal before or shortly after birth. | * '''Hydrops Fetalis''': Four gene deletions, usually fatal before or shortly after birth. | ||
==Clinical Features== | ==Clinical Features== | ||
The clinical presentation of alpha-thalassemia varies depending on the number of affected genes. | The clinical presentation of alpha-thalassemia varies depending on the number of affected genes. | ||
===Silent Carrier=== | ===Silent Carrier=== | ||
Individuals with one deleted alpha-globin gene are typically asymptomatic and have normal hematological parameters. | Individuals with one deleted alpha-globin gene are typically asymptomatic and have normal hematological parameters. | ||
===Alpha-thalassemia Trait=== | ===Alpha-thalassemia Trait=== | ||
Individuals with two deleted alpha-globin genes may have mild anemia and microcytosis. They are often asymptomatic and may be identified during routine blood tests. | Individuals with two deleted alpha-globin genes may have mild anemia and microcytosis. They are often asymptomatic and may be identified during routine blood tests. | ||
===Hemoglobin H Disease=== | ===Hemoglobin H Disease=== | ||
This condition results from the deletion of three alpha-globin genes. It is characterized by: | This condition results from the deletion of three alpha-globin genes. It is characterized by: | ||
* Moderate to severe anemia | * Moderate to severe anemia | ||
* Splenomegaly | * Splenomegaly | ||
* Jaundice | * Jaundice | ||
* Bone deformities | * Bone deformities | ||
===Hydrops Fetalis=== | ===Hydrops Fetalis=== | ||
This is the most severe form of alpha-thalassemia, resulting from the deletion of all four alpha-globin genes. It leads to: | This is the most severe form of alpha-thalassemia, resulting from the deletion of all four alpha-globin genes. It leads to: | ||
* Severe anemia | * Severe anemia | ||
* Heart failure | * Heart failure | ||
* Edema | * Edema | ||
* Usually results in stillbirth or death shortly after birth | * Usually results in stillbirth or death shortly after birth | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of alpha-thalassemia involves: | Diagnosis of alpha-thalassemia involves: | ||
* Complete blood count (CBC) showing microcytic anemia | * Complete blood count (CBC) showing microcytic anemia | ||
* Hemoglobin electrophoresis | * Hemoglobin electrophoresis | ||
* Genetic testing to identify deletions in the HBA1 and HBA2 genes | * Genetic testing to identify deletions in the HBA1 and HBA2 genes | ||
==Management== | ==Management== | ||
Management of alpha-thalassemia depends on the severity of the disease: | Management of alpha-thalassemia depends on the severity of the disease: | ||
* '''Silent Carrier and Alpha-thalassemia Trait''': Usually require no treatment. | * '''Silent Carrier and Alpha-thalassemia Trait''': Usually require no treatment. | ||
* '''Hemoglobin H Disease''': May require regular blood transfusions, folic acid supplementation, and splenectomy in severe cases. | * '''Hemoglobin H Disease''': May require regular blood transfusions, folic acid supplementation, and splenectomy in severe cases. | ||
* '''Hydrops Fetalis''': Prenatal diagnosis and counseling are important. Intrauterine transfusions may be considered. | * '''Hydrops Fetalis''': Prenatal diagnosis and counseling are important. Intrauterine transfusions may be considered. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis of alpha-thalassemia varies: | The prognosis of alpha-thalassemia varies: | ||
* Silent carriers and individuals with alpha-thalassemia trait generally have a normal life expectancy. | * Silent carriers and individuals with alpha-thalassemia trait generally have a normal life expectancy. | ||
* Hemoglobin H disease can lead to complications but is manageable with treatment. | * Hemoglobin H disease can lead to complications but is manageable with treatment. | ||
* Hydrops fetalis is usually fatal without intervention. | * Hydrops fetalis is usually fatal without intervention. | ||
==Prevention== | ==Prevention== | ||
Genetic counseling is recommended for at-risk couples. Prenatal testing can identify affected fetuses, allowing for informed decision-making. | Genetic counseling is recommended for at-risk couples. Prenatal testing can identify affected fetuses, allowing for informed decision-making. | ||
==See Also== | ==See Also== | ||
* [[Thalassemia]] | * [[Thalassemia]] | ||
* [[Hemoglobinopathy]] | * [[Hemoglobinopathy]] | ||
* [[Anemia]] | * [[Anemia]] | ||
{{Thalassemia}} | {{Thalassemia}} | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Blood disorders]] | [[Category:Blood disorders]] | ||
Latest revision as of 22:16, 5 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Alpha-thalassemia | |
|---|---|
| |
| Synonyms | α-thalassemia |
| Pronounce | |
| Specialty | Hematology |
| Symptoms | Anemia, fatigue, pallor, jaundice, splenomegaly |
| Complications | Hydrops fetalis, iron overload |
| Onset | Birth |
| Duration | Lifelong |
| Types | Alpha-thalassemia trait, Hemoglobin H disease, Hemoglobin Bart's hydrops fetalis |
| Causes | Genetic mutations in the HBA1 and HBA2 genes |
| Risks | Family history, Southeast Asian, Mediterranean, Middle Eastern, African descent |
| Diagnosis | Complete blood count, hemoglobin electrophoresis, genetic testing |
| Differential diagnosis | Beta-thalassemia, iron deficiency anemia, sideroblastic anemia |
| Prevention | Genetic counseling |
| Treatment | Blood transfusion, iron chelation therapy, bone marrow transplant |
| Medication | Deferoxamine, Deferasirox |
| Prognosis | Variable, depending on type |
| Frequency | Common in certain populations |
| Deaths | N/A |
Alpha-thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen to cells throughout the body. Alpha-thalassemia is caused by mutations in the HBA1 and HBA2 genes, which are responsible for the production of alpha-globin, a component of hemoglobin.
Pathophysiology[edit]
In alpha-thalassemia, the production of alpha-globin chains is reduced or absent. This leads to an imbalance in the ratio of alpha to beta-globin chains, resulting in the formation of abnormal hemoglobin molecules. The severity of the disease depends on the number of affected alpha-globin genes.
Genetic Basis[edit]
The HBA1 and HBA2 genes are located on chromosome 16. Each person has four alpha-globin genes, two from each parent. The severity of alpha-thalassemia is determined by the number of gene deletions:
- Silent Carrier: One gene deletion, usually asymptomatic.
- Alpha-thalassemia Trait: Two gene deletions, mild anemia.
- Hemoglobin H Disease: Three gene deletions, moderate to severe anemia.
- Hydrops Fetalis: Four gene deletions, usually fatal before or shortly after birth.
Clinical Features[edit]
The clinical presentation of alpha-thalassemia varies depending on the number of affected genes.
Silent Carrier[edit]
Individuals with one deleted alpha-globin gene are typically asymptomatic and have normal hematological parameters.
Alpha-thalassemia Trait[edit]
Individuals with two deleted alpha-globin genes may have mild anemia and microcytosis. They are often asymptomatic and may be identified during routine blood tests.
Hemoglobin H Disease[edit]
This condition results from the deletion of three alpha-globin genes. It is characterized by:
- Moderate to severe anemia
- Splenomegaly
- Jaundice
- Bone deformities
Hydrops Fetalis[edit]
This is the most severe form of alpha-thalassemia, resulting from the deletion of all four alpha-globin genes. It leads to:
- Severe anemia
- Heart failure
- Edema
- Usually results in stillbirth or death shortly after birth
Diagnosis[edit]
Diagnosis of alpha-thalassemia involves:
- Complete blood count (CBC) showing microcytic anemia
- Hemoglobin electrophoresis
- Genetic testing to identify deletions in the HBA1 and HBA2 genes
Management[edit]
Management of alpha-thalassemia depends on the severity of the disease:
- Silent Carrier and Alpha-thalassemia Trait: Usually require no treatment.
- Hemoglobin H Disease: May require regular blood transfusions, folic acid supplementation, and splenectomy in severe cases.
- Hydrops Fetalis: Prenatal diagnosis and counseling are important. Intrauterine transfusions may be considered.
Prognosis[edit]
The prognosis of alpha-thalassemia varies:
- Silent carriers and individuals with alpha-thalassemia trait generally have a normal life expectancy.
- Hemoglobin H disease can lead to complications but is manageable with treatment.
- Hydrops fetalis is usually fatal without intervention.
Prevention[edit]
Genetic counseling is recommended for at-risk couples. Prenatal testing can identify affected fetuses, allowing for informed decision-making.
